Clinical Trial Update: Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pazopanib versus placebo in soft tissue sarcoma patients whose disease progressed after prior therapy; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sarcoma, Soft Tissue | Phase 3 | Status: COMPLETED | Results posted: 2011-12-21